Surrozen, Inc./DE
Develops regenerative antibodies modulating the Wnt pathway to repair tissues and restore organs.
SRZN | US
Overview
Corporate Details
- ISIN(s):
- KYG2445M1033 (+2 more)
- LEI:
- Country:
- United States of America
- Address:
- 171 OYSTER POINT BLVD, 94080 SOUTH SAN FRANCISCO
- Website:
- https://www.surrozen.com
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Surrozen, Inc. is a clinical-stage biotechnology company that discovers and develops drug candidates to repair tissues and restore organs damaged by serious diseases. The company is pioneering a new class of targeted regenerative antibodies designed to selectively modulate the Wnt pathway, a key biological mechanism for the body's natural repair and self-renewal processes. Surrozen's platform develops tissue-specific antibodies with a current focus on therapeutic areas such as ophthalmology. The company's mission is to unlock the body's regenerative power to transform the treatment of a broad range of injuries and diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Surrozen, Inc./DE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Surrozen, Inc./DE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Surrozen, Inc./DE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
